Alto Neuroscience Funding & Investors

Los Altos, CA

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

Total Amount Raised: $239,261,808

IPO
Unknown
Jan 1, 2024
Series Unknown
$59,261,815
Nov 26, 2023
Series C
$45,000,000
Nov 20, 2023
Series C Investors
InVivium Capital
Lightswitch Capital
Windham Venture Partners
Eli Lilly and Company
Franklin Resources, Inc.
What If Ventures
Alkeon Capital Management
Alexandria Venture Investments
Point72 Ventures
Alpha Wave Ventures
Series B
$25,000,000
Jan 29, 2023
Series B Investors
Alpha Wave Ventures
THE CATALYTIC IMPACT FOUNDATION (CIF)
Debt Financing
$35,000,000
Jan 29, 2023
Debt Financing Investors
K2 HealthVentures
Series B
$35,000,000
Oct 24, 2022
Series B Investors
Alkeon Capital Management
Lightswitch Capital
What If Ventures
Sobrato Organization
Apeiron Investment Group
Vine Ventures
Windham Venture Partners
Novartis Pharma
Korify Capital
Gaingels
VALOR
Presight Capital
infinitas capital
Series A
$32,000,000
May 2, 2021
Series A Investors
Apeiron Investment Group
Presight Capital
Stanford University
Risk and Return
What If Ventures
Able Partners
Windham Venture Partners
Tim Kendall
Korify Capital
PsyMed Ventures
Seed
$8,000,000
Sep 18, 2019
Seed Investors
Tim Kendall

Funding info provided by Diffbot.